PATENT CLAIM ANALYSIS

Application Number: 15946106
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2019-04
Patent Classification: ["435", "006120"]

Abstract:
Described herein is the Identification of the NMT isozyme overexpressed in PBMCs of colorectal cancer patients and the cell types overexpressing NMT2 in the PBMCs of CRC patients.

Claim (Index 12):
The method according to  claim 1  including performing a biopsy on any tissue sample removed during the sigmoidoscopy or colonoscopy for diagnosing colorectal cancer.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.38095
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11992697', '12452035', '12180113', '12452038', '12452048']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5625079976565507
- 35 USC 102 Novelty (BERT): 0.5181460527951309
- Combined Prediction Score: 0.5580718031704087
- Mean Citation Score: 252.205236
- Max Citation Score: 293.2865
- Similarity Product: 211.995213717878

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test